A novel approach to accurately measuring the burden of hospitalisations for cardiovascular disease in people with diabetes: A pilot study
Diabetic Medicine · 2024
DOI: 10.1111/dme.15291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, 2024. Verfasst von Quan Huynh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Hospitalization, Cardiovascular Diseases. Die Arbeit nennt 18 Literaturangaben. Gefördert von: AstraZeneca Australia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To determine the reliability of hospital discharge codes for heart failure (HF), acute myocardial infarction (AMI) and stroke compared with adjudicated diagnosis, and to pilot a scalable approach to adjudicate records on a population‐based sample.
Methods
A population‐based sample of 685 people with diabetes admitted (1274 admissions) to one of three Australian hospitals during 2018–2020 were randomly selected for this study. All medical records were reviewed and adjudicated.
Results
Cardiovascular diseases were the most common primary reason for hospitalisation in people with diabetes, accounting for ~17% (215/1274) of all hospitalisations, with HF as the leading cause. ICD‐10 codes substantially underestimated HF prevalence and had the lowest agreement with the adjudicated diagnosis of HF (Kappa = 0.81), compared with AMI and stroke (Kappa ≥ 0.91). While ICD‐10 codes provided suboptimal sensitivity (72%) for HF, the performance was better for AMI (sensitivity 84%; specificity 100%) and stroke (sensitivity 85%; specificity 100%). A novel approach to screen possible HF cases only required adjudicating 8% (105/1274) of records, correctly identified 78/81 of HF admissions and yielded 96% sensitivity and 98% specificity.
Conclusions
While ICD‐10 codes appear reliable for AMI or stroke, a more complex diagnosis such as HF benefits from a two‐stage process to screen for suspected HF cases that need adjudicating. The next step is to validate this novel approach on large multi‐centre studies in diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
- Royal Hobart Hospital, Hobart, Tasmania, Australia.
- School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.
- Western Health, Melbourne, Victoria, Australia.
- Alfred Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Quan Huynh
Förderung
- AstraZeneca Australia
Zitieren
APA
Huynh, Q., Burgess, J., Flentje, K., Tan, N., Batchelor, R., Marwick, T. H., & Shaw, J. E. (2024). A novel approach to accurately measuring the burden of hospitalisations for cardiovascular disease in people with diabetes: A pilot study. Diabetic Medicine. https://doi.org/10.1111/dme.15291
Vancouver
Huynh Q, Burgess J, Flentje K, Tan N, Batchelor R, Marwick TH, et al. A novel approach to accurately measuring the burden of hospitalisations for cardiovascular disease in people with diabetes: A pilot study. Diabetic Medicine. 2024. doi:10.1111/dme.15291
BibTeX
@article{Huynh2024,
author = {Huynh, Quan and Burgess, John and Flentje, Kate and Tan, Neville and Batchelor, Riley and Marwick, Thomas H and Shaw, Jonathan E},
title = {A novel approach to accurately measuring the burden of hospitalisations for cardiovascular disease in people with diabetes: A pilot study},
journal = {Diabetic Medicine},
year = {2024},
doi = {10.1111/dme.15291}
}
EUVIMED